MetLife Investment Management, LLC

Position in DTIL — Precision Biosciences Inc

CIK 1529735 Whippany, NJ

Position in DTIL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$114,315

-$26,580 QoQ

Shares Held

14,544

+2190.4% QoQ

Ownership

0.053%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#54

of 95 holders

Holding Since

Mar 2020

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $430,307,229 across 249 Biotechnology names. DTIL ranks #232 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	402,605	$31,511,893
2	PRAX	Praxis Precision Medicines, Inc.	90,543	$30,312,890
3	VRTX	Vertex Pharmaceuticals Inc / Ma	58,072	$28,846,104
4	FTRE	Fortrea Holdings Inc.	1,362,169	$23,701,740
5	AXSM	Axsome Therapeutics, Inc.	89,662	$21,946,567
6	IMNM	Immunome Inc.	859,076	$18,203,820
7	REGN	Regeneron Pharmaceuticals, Inc.	22,880	$14,266,595
8	CYTK	Cytokinetics Inc	140,046	$11,930,518

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$114,315	14,544	-23.6%	Shares	Defined	2026-08-14
2021-12-31	$140,895	19,040	+56.6%	Shares	Defined	2024-05-17
2021-09-30	$140,268	12,155	-34.9%	Shares	Defined	2024-05-17
2021-06-30	$233,898	18,682	+117.0%	Shares	Defined	2024-05-17
2021-03-31	$89,103	8,609	-59.6%	Shares	Defined	2024-05-17
2020-12-31	$177,600	21,295	-21.8%	Shares	Defined	2024-05-24
2020-09-30	$167,675	27,220	0.0%	Shares	Defined	2024-05-24
2020-06-30	$226,742	27,220	+57.7%	Shares	Defined	2024-05-24
2020-03-31	$104,083	17,261	—	Shares	Defined	2023-07-12
No filing history on record for this holder in this stock.